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Elm tree bark extract inhibits HepG2 hepatic cancer cell growth via 
pro-apoptotic activity 
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College of Veterinary Medicine, Chungbuk National University, Cheongju 361-763, Korea
Control of inflammation is widely accepted as an important 
strategy  for  cancer  chemoprevention.  Anti-inflammatory 
effects of bark extracts of elm tree (BEE) have been amply 
reported. Therefore, BEE may be a good candidate cancer 
chemopreventive agent. Considering the high incidence of 
hepatic  cancer  and  limited  therapeutic  approaches  for 
treating  this  disease,  it  is  important  to  develop  liver 
cancer-specific  chemopreventive  agents.  To  evaluate  the 
chemopreventive  potential  of  BEE,  we  investigated  the 
growth  inhibition  effect  of  BEE  on  the  HepG2  human 
hepatocellular  carcinoma  cell  line.  We  performed  a  cell 
counting  kit-8  assay  to  determine  cell  viability,  and 
4,6-diamino-2-phenylindole staining and flow cytometry to 
measure apoptotic cell death. Finally, the expression levels 
of pro- and anti-apoptotic proteins were measured. BEE 
inhibited the growth of HepG2 cells and induced apoptosis 
in  a  dose-dependent  manner.  Pro-apoptotic  activity  was 
promoted via the mitochondrial pathway of apoptosis, as 
demonstrated by the activation of pro-apoptotic proteins 
Bax, caspase-9, caspase-3, and poly (ADP-ribose) polymerase 
as well as the down-regulation of the anti-apoptotic protein 
Bcl-2. These results suggest that BEE may have potential use 
in hepatic cancer chemoprevention by suppressing cancer 
cell growth via pro-apoptotic activity.
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davidiana
Introduction
Hepatocellular carcinoma (HCC) is a primary malignancy 
of hepatocytes which accounts for 80% of all primary liver 
cancers and ranks globally as the fourth leading cause of 
cancer-related death [1]. HCC is a major public health 
issue in Korea due to its high incidence related to chronic 
infection with hepatitis B and C virus [19]. In addition to 
viral infections, several etiological risk factors have been 
identified including alcohol abuse, expose to aflatoxin B1, 
and nonalcoholic fatty liver change [16]. HCC frequently 
arises in patients with liver cirrhosis, the result of a 
complex pathogenesis involving chronic hepatitis, necrosis, 
and regenerative fibrosis. Since terminal stage HCC can 
rarely be cured by conventional therapeutic approaches, 
the final remaining therapeutic choices are surgical 
resection and transplantation [13]. However, the survival 
rate of HCC patients who have undergone surgical 
resection is known to be less than 25% [31]. Therefore, 
development of an effective cancer chemopreventive agent 
is urgently needed for hepatic cancer prevention. Cancer 
chemoprevention is defined as an attempt to suppress or 
prevent the carcinogenic progression with natural or 
synthetic chemical agents. These agents might prevent or 
reverse the carcinogenic progression during the premalignant 
or early stages by inducing the apoptosis of cancerous cells 
or inducing differentiation.
The elm tree (Ulmus davidiana var. japonika Nakai) is a 
deciduous tree that is naturally widespread throughout 
Korea, Japan, and China. The bark of the stem and root of 
this plant have long been used in Oriental medicine to treat 
inflammation, edema, mastitis, cancer, and rheumatoid 
arthritis [22]. The phytochemical components of bark 
extracts of elm tree (BEE) include (+)-catechin, catechin 
rhamnoside, catechin apiofuranoside, triterpene esters, 
sesquiterpene o-naphthaquinones (mansonones E, F, H), 
lignan, and neolignan glycosides [15,27]. Methanolic 
extracts of the elm tree exhibit strong anti-oxidant activity 
in animal models including 1,1-diphenyl-2-picrylhydrazyl 
radical scavenging and hydroxyl radical scavenging [12], 
and inhibit endogenous nitric oxide synthesis in macrophages 
[11]. Moreover, the plant glycoprotein (approximately 116 
kDa) has biologically active functions that include 8     Tae Myoung Kim et al.
anti-oxidative properties, the ability to enhance immune 
activity [20]. This compound also inhibits the activation of 
inducible nitric oxide synthase, cyclooxygenase-2, and 
matrix metalloproteinase-9 by blocking activator protein-1 
and nuclear factor-kappa B in lipopolysaccharide-stimulated 
HCT-116 cells [23]. Mansonone E and F, two sesquiterpene 
O-naphthoquinone compounds isolated from BEE, exert 
anti-proliferative and pro-apoptotic effects on HeLa cells 
that involve the down-regulation of Bcl-2 and Bcl-xL 
along with the up-regulation of Bax, thereby leading to the 
initiation of the mitochondrial apoptotic pathway [30]. 
Additionally, mansonone E was found to have anti-tumor 
activities in a nude mouse xenograft model of colon cancer 
and in uterine cancer cells [21]. The anti-cancer properties 
of BEE were also observed in cancer cell lines and a 
1,2-dimethylhydrazine-induced rat colorectal carcinogenesis 
model [5,18]. In one of the latter studies, BEE decreased 
the incidence of aberrant crypt foci and reduced crypt 
multiplicity, thus inducing apoptosis in the region of the 
colon where most of the pre-neoplastic lesions had 
accumulated [18].
Although the attributes mentioned above are germane to 
the use of elm tree as a traditional medication, the me-
chanism(s) of BEE action should be thoroughly elucidated 
before applying this compound to treat human health 
problems. In particular, no study of the modulating effects 
of BEE on the growth of hepatic cancer cells has been 
documented. The present study was therefore performed to 
investigate the effects of BEE on the growth of HepG2 
human HCC cells. The effects of BEE on apoptosis and 
possible impact on the apoptotic pathway were studied.
Materials and Methods
Isolation of BEE chloroform faction
An elm tree was purchased from the Eoleumgol 
Agricultural Cooperative Union, Korea. A voucher 
specimen was deposited at College of Agriculture, Life 
and Environment Sciences, Chungbuk National 
University, Korea. Fresh root bark (10 kg) was dried in a 
dark and well-ventilated place. The air-dried root bark 
samples were milled and underwent an extraction process 
three times with 80% ethanol at 25
oC at 3.78 × g under 
reflux. The ethanol extract of elm tree root was filtered 
through Whatman filter paper (No. 2; Maidstone, England), 
and concentrated in a rotary vacuum evaporator (N-11; 
Eyela, Japan) at 40
oC. The yield of the ethanol extract was 
1.41% of the raw material mass. For solvent fractionation, 
BEE (4 g) was suspended in water, and then underwent a 
series of extractions successively with equal volumes of 
n-hexane, chloroform, ethyl acetate, and n-butanol, leaving a 
residual aqueous fraction. Each fraction was evaporated 
in vacuo to yield the residues of the hexane (15.7%), 
chloroform (27.3%), ethyl acetate (7.2%), butanol (29.6%), 
aqueous (20.2%) fractions. The final components in 
chloroform-soluble fraction of the ethanol extract were 
used for the experiment.
Cell culturing
HepG2 human HCC cells were obtained from the Korean 
Cell Line Bank (Korea). The cells were cultured in 
Dulbecco’s modified Eagles’s medium (Hyclone, USA) 
supplemented with 10% fetal bovine serum (Hyclone, USA), 
100 U/mL penicillin, and 100 μg/mL streptomycin (GIBCO, 
USA) at 37
oC in a 5% CO2 humidified atmosphere. 
Cell viability assay
HepG2 cells were plated at a density of 1 × 10
4 cells/well 
in 96-well plates (BD Biosciences, USA). Each well 
contained 100 μL of culture medium. To determine the 
appropriate concentration that was not cytotoxic, cells 
cultured for 24 h were evaluated using a cell counting kit-8 
(CCK-8) assay kit (Dojindo Molecular Technologies, 
USA) according to the manufacturer’s instructions. Briefly, 
10 μL of a CCK-8 solution was added to each well. The 
plates were incubated for 3∼4 h at 37
oC. The resulting 
color was analyzed using a microplate absorbance reader 
(BioTek, USA). Each assay was carried out in triplicate. 
The optical density (OD) was measured at 450 nm and the 
percent viability was calculated as (OD of the drug-treated 
sample/OD of the non-treated sample) × 100.
4,6-diamino-2-phenylindole (DAPI) staining 
Apoptotic cells were identified by DAPI staining. After 
overnight culturing in an 8-well plate (BD Biosciences, 
USA) (4 × 10
5 cells/mL), the HepG2 cells were treated 
with various concentrations (0, 50, 100 and 200 μg/mL) of 
BEE in fresh culture medium at 37
oC for 24 h. The cells 
were then fixed with 500 μL fixing solution (acetic 
acid : methanol; 1 : 3) for 5 min, dried, and stained with 
the DNA-specific fluorochrome DAPI (2 μg/mL; 
Sigma-Aldrich, USA). Following 10 min of incubation, 
the cells were washed with phosphate buffered saline 
(PBS), air-dried, mounted with 90% (v/v) glycerol, and 
examined using a fluorescence microscope (Olympus, Japan).
Quantification of apoptotic cells by flow cytometry
BEE-induced apoptosis in HepG2 cells was determined 
after labeling with fluorescein isothiocyanate (FITC) 
annexin-V stain supplied in an apoptosis detection kit (BD 
Biosciences, USA) that was used according to the 
manufacturer’s instructions. The labeled cells were analyzed 
using flow cytometry. Briefly, after overnight culturing in a 
6-well plate (1 × 10
5 cells/well;  BD Biosciences, USA), 
HepG2 cells were treated with 0, 50, 100, or 200 μg/mL of 
BEE in fresh culture medium at 37
oC for 24 h. Both 
floating and adherent cells were concentrated and 
suspended in binding buffer (10 mM HEPES, 140 mM  Pro-apoptotic effect of Ulmus davidiana extract    9
Fig. 2. The fluorescence microscopic morphology of HepG2 
cells treated with BEE. Note the enhanced DNA fragmentations
and apoptotic body (arrows) formations in cells treated with 
200 μg/mL of BEE. ×200. 
Fig. 1. Bark extracts of elm tree (BEE) influences the viability of 
HepG2 hepatocellular carcinoma (HCC) cells. Data are 
expressed as the mean ± SD. *Significantly different from the 
control (p ＜ 0.05).
NaCl, and 2.5 mM CaCl2, pH 7.4). The mixture was then 
incubated for 20 min in the dark at room temperature and 
analyzed by fluorescence-activated cell sorting (FACS) 
using a FACSCalibur instrument (BD Biosciences, USA).
Western blot analysis
Cultured cells were washed twice with 1 × PBS followed 
by the addition of 1 mL of PBS. The cells were then scraped 
into a cold 1.5 mL microtube. Cells were homogenized in 
100 μL lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 
0.02% sodium azide, 0.2% sodium dodecyl sulfate (SDS), 
1 mM phenyl methane sulfonyl fluoride, 10 μL/mL 
aprotinin, 1% IGEPAL 630, 10 mM NaF, 0.5 mM EDTA, 
0.1 mM EGTA, and 0.5% sodium deoxycholate; Sigma- 
Aldrich, USA) and centrifuged at 23,000 × g for 15 min. 
The protein concentration was measured using the 
Bradford method (Bio-Rad Laboratories, USA) and equal 
amounts of proteins (40 μg) were separated by 10% or 
12.5% SDS-polyacrylamide gel electrophoresis. The 
resolved proteins were transferred to an immobilon 
polyvinylidene fluoride membrane (Millipore, USA). The 
membranes were blocked for 1.5 h at room temperature 
with 5% (w/v) non-fat dried milk in a Tris-buffered saline 
(10 mM Tris, pH 8.0 and 150 mM NaCl) solution 
containing 0.05% Tween-20. The membrane was incubated 
for 2∼5 h at room temperature or overnight at 4
oC with 
antibodies against inducible Bax, Bcl-2, poly (ADP-ribose) 
polymerase (PARP), caspase-3, and caspase-9 (1 : 500∼
1,000 dilution; Cell Signaling Technology, USA). The blot 
was then incubated with the approperiate horseradish 
peroxidase-conjugated anti-rabbit or anti-mouse IgG (1 : 
2,000∼3,000 dilutions; Cell Signaling Technology, USA). 
Immunoreactive proteins were detected with the West-zol 
Western Blot Detection System (iNtRON Biotechnology, 
Korea). The relative density of the protein bands was 
measured by densitometry using Image J (National 
Institutes of Health, USA).
Statistics
The results are expressed as the mean ± SD. Data were 
analyzed by Tukey’s HSD test after performing a one-way 
analysis of variance by using SPSS software (ver. 12.0; 
SPSS, USA). p-values less than 0.05 were considered to be 
significant.
Results
BEE suppresses the viability of HepG2 cells
HepG2 cells were treated with 0∼800 μg/mL of BEE for 
up to 24 h after which cell viability was analyzed with a 
CCK-8 assay. Starting at a concentration of 100 μg/mL, 
BEE significantly suppressed the viability of the HepG2 
cells in a dose-dependent manner (p ＜ 0.05; Fig. 1). 
BEE induces apoptotic cell death 
To ascertain whether the BEE inhibition of cell growth 
was due to the induction of apoptosis, changes in chromatin 
morphology of the HepG2 cells were examined. HepG2 
cells were exposed to 0, 50, 100, and 200 μg/mL of BEE, 
and DNA fragmentation was detected by DAPI staining. 
After incubating for 24 h, enhanced DNA fragmentation 
and apoptotic bodies were observed in cells treated with a 
high dose (100 and 200 μg/mL) of BEE (Fig. 2). To 
quantify the number of apoptotic cells treated with BEE, a 
FITC annexin-V flow cytometry analysis was performed. 
A representative flow cytometric analysis showed that the 
percentage of apoptotic cells were 4.48%, 12.10%, 23.52%, 10     Tae Myoung Kim et al.
Fig.  3. Effect of BEE on HepG2 HCC cell apoptosis. After 24 h, the collected cells were incubated with a fluorescein isothiocyanate
(FITC)-annexin V stain to detect apoptosis (A). BEE increased the number of apoptotic cells in a dose-dependent manner (B). Data 
represent the mean ± SD. *Significantly different from the control (p ＜ 0.05).
and 36.45% of the HepG2 population treated with 0, 50, 
100, and 200 μg/mL BEE, respectively (Fig. 3A). BEE 
significantly increased the number of apoptotic cell deaths 
in a dose-dependent manner (p ＜ 0.05; Fig. 3B).
Expression of apoptosis-related proteins
Since Bax and Bcl-2 play a crucial role in the apoptotic 
pathway, we examined the effect of BEE treatment on the 
expression of these two proteins. BEE treatment enhanced 
the expression of the pro-apoptotic protein Bax while the 
level of the anti-apoptotic protein Bcl-2 decreased in a 
dose-dependent manner (Fig. 4). Since the alteration of 
Bax/Bcl-2 is known to initiate caspase-9 signaling, the 
effect of BEE on caspase-9 and caspase-3 was evaluated. 
BEE treatment resulted in increased expression of cleaved 
caspase-9 and caspase-3 in a dose-dependent manner 
although a significant difference was observed only for 
caspase-3 expression (Fig. 4). Additionally, cleavage of 
PARP (116 kDa), one of the substrates of activated 
caspase-3, was measured. Increased levels of an 85-kDa 
PARP fragment was observed a dose-dependent fashion 
after incubating for 24 h.
Discussion
Chemoprevention is defined as the use of natural or 
synthetic compounds to prevent or suppress the progre-
ssion of cancers. Numerous efforts are being devoted 
worldwide to discover natural compounds that have 
potential to suppress cancer cell growth. Many herbal 
products are available as traditional medicines for cancer 
prevention. However, not much is known about their 
efficacy, active principles, mode of action, side effects, or 
possible adverse interactions with conventional antitumor 
agents. Therefore, in vitro testing of herbal agents in 
cancer cell lines may be helpful for understanding their 
mechanism of action and discovering potential effects. 
Two different mechanisms are usually employed in cancer 
chemoprevention: modulation of cell proliferation and 
induction of cell differentiation. 
The present study examined the chemopreventive effects 
of ethanolic elm tree extract on a hepatic cancer cell line. In 
order to screen for cytotoxic or apoptotic activities, this 
study initially determined whether BEE is capable of 
inhibiting cell proliferation or inducing apoptosis. The 
colorimetric CCK-8 assay showed that the numbers of 
formazan-producing cells decreased with increasing doses 
of BEE; 50% and 66% cytotoxicity was observed with 400 
and 800 μg/mL of BEE, respectively. In addition, mor-
phological changes typical of apoptosis were observed in 
BEE-treated cells. The presence of apoptotic bodies 
defined as fragments of condensed nuclei was confirmed 
by DAPI staining. The number of apoptotic bodies 
increased in a dose-dependent manner. Morphological 
changes in cell shape and chromatin condensation are the 
basic and classical criteria for identifying apoptotic cells  Pro-apoptotic effect of Ulmus davidiana extract    11
Fig. 4. Effect of BEE on the expression of apoptotic proteins in HepG2 HCC cells. β-actin was used as an internal control (A). BEE
increased the Bax/Bcl-2 ratio and expression of caspase-3, caspase-9, and PARP (B). Data represent the mean ± SD. *Significantly 
different from the control (p ＜ 0.05).
[14]. These changes are caused by the activation of 
caspases, proteolytic enzymes that are central factors of 
apoptosis [4].
Apoptosis is a mechanism in all metazoans for regulating 
tissue homeostasis through the elimination of redundant or 
potentially deleterious cells. The induction of apoptosis is 
arguably the most potent defense system against cancer. 
For example, immune cells use apoptosis to destroy 
cancerous cells [10,29], and most chemotherapeutic agents 
inhibit tumor cell proliferation by inducing apoptosis 
[3,26]. The triggering of apoptosis, referred to as the 
initiation phase, is highly dependent on cell type and 
apoptotic stimuli such as receptor-ligand binding, oxidative 
stress, radiation, and cytokines [17]. In the subsequent 
effector phase, cells undergo distinct biochemical changes 
that result in the systematic activation of procaspase-8, -9, 
and other factors [7,25]. Activation of these enzymes leads 
to the execution of related to apoptotic factors and 
degradation phase through the cleavage of proteins 
such as caspase-3 and fragmentation of DNA [8,29]. 
Most of the recent advances in elucidating the apoptotic 
pathways have come about through the characterization of 
effector mechanisms. Effector mechanisms of apoptosis 
have several components. Two effector mechanisms 
associated with caspase activation have been extensively 
characterized: the extrinsic or death receptor-mediated 
mechanism, and the intrinsic or mitochondrial-mediated 
mechanism [9]. In addition to the mitochondria, other 
organelles including the endoplasmic reticulum, golgi 
apparatus, and lysosomes may also have a role in sensing 12     Tae Myoung Kim et al.
cell damage, pro-apoptotic signaling, and caspase 
activation [6]. The extrinsic apoptotic pathway is 
activated at the cell surface when a specific ligand binds 
to its corresponding cell surface death receptor.
The intrinsic apoptotic pathway relies solely on the 
permeabilization of mitochondrial membranes to release 
apoptogenic mitochondrial proteins such as cytochrome c 
[24] and apoptosis-inducing factor (AIF) [28]. Cytochrome c 
released into the cytosol triggers the caspase-dependent 
apoptotic pathway [24]. In contrast, AIF induces 
caspase-independent apoptosis [33]. In this pathway, Bcl-2 
family members appear to play an important role in the 
regulation of apoptosis. With cell stress, anti-apoptotic 
Bcl-2 family members (e.g., Bcl-2 and Bcl-xL) residing in 
the outer mitochondrial membrane can be destabilized by 
the induction of pro-apoptotic bcl-2 family members (e.g., 
Bax, Bad, and Bak). In this scenario, the increased ratio of 
pro-apoptotic Bcl-2 family members to anti-apoptotic 
Bcl-2 family members induces the release of cytochrome c 
which binds to Apaf-1, leading to activation of 
procaspase-9 and subsequent activation of procas-
pase-3 [3,28,29]. Activated caspase-3 is the key 
mediator of apoptosis that induces the cleavage and 
inactivation of key cellular proteins such as PARP 
[29,32]. 
In the present study, flow cytometry and DAPI staining 
showed that BEE treatment induced a significant 
accumulation of apoptotic cells and increased the number 
of apoptotic bodies in HepG2 cells. BEE (200 μg/mL) 
significantly increased the ratio of Bax/Bcl-2 protein in 
HepG2 cells as detected by Western blot analysis, 
suggesting that BEE induces apoptosis via the intrinsic 
mitochondrial-dependent pathway. However, the increase 
of activated caspase-9 and PARP was not significant 
although activated caspase-3 levels significantly increased. 
These findings indicate that BEE possibly induced 
apoptosis via the caspase-9-independent pathway as well. 
The exact mechanism of apoptosis induced by BEE should 
be further elucidated. In particular, it will be important to 
determine whether and by how much the expression of 
molecules involved in the caspase-9-independent pathway, 
such as AIF, is affected.
Regarding the active compounds included in BEE, several 
candidate compounds such as bakuchiol, mansonone E and 
F, glycoproteins, and catechins were documented [2, 
20,27,30]. Those compounds are known to have diverse 
biological effects including anti-inflammatory, pro- 
apoptotic, and anti-oxidative properties according to the 
isolation method or type of cell line [20,30]. In particular, 
bakuchiol and masonone E and F are known to be major 
components in ethanolic BEE that exert anti-inflammatory 
or pro-apoptotic effects [2]. Therefore, we assume that 
these compounds might have been included in the BEE 
and influenced our results.
In summary, we found that BEE inhibited the growth of 
HepG2 cells by activating the mitochondrial pathway of 
apoptosis. These results suggest that elm tree root extract 
may have therapeutic potential for suppressing liver 
carcinogenesis. The various components of BEE res-
ponsible for these actions should be determined by future 
studies.
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